EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 14 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 106,561 | $304,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 243,790 | $695,000 | 0.03% |
| Vantage Investment Advisors, LLC | 6,500 | $19,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,693 | $28,000 | 0.00% |
| UBS Group AG | 3,964 | $11,000 | 0.00% |
| MORGAN STANLEY | 1,199 | $3,000 | 0.00% |
| DEUTSCHE BANK AG\ | 646 | $1,000 | 0.00% |